Home
>
National Drug Code (NDC)
>
Evoxac
Evoxac - 63395-201-13 - (cevimeline hydrochloride)
Drug Information of Evoxac
| Product NDC: | 63395-201 |
| Proprietary Name: | Evoxac |
| Non Proprietary Name: | cevimeline hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; cevimeline hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Evoxac
| Product NDC: | 63395-201 |
| Labeler Name: | Daiichi Sankyo Pharma Development |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020989 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000112 |
Package Information of Evoxac
| Package NDC: | 63395-201-13 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (63395-201-13) |
NDC Information of Evoxac
| NDC Code | 63395-201-13 |
| Proprietary Name | Evoxac |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (63395-201-13) |
| Product NDC | 63395-201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cevimeline hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20000112 |
| Marketing Category Name | NDA |
| Labeler Name | Daiichi Sankyo Pharma Development |
| Substance Name | CEVIMELINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
